The identification of specific genetic changes associated with differences in the pathogenicity of Marek's disease virus strains (GaHV-2) has been a formidable task due to the large number of mutations in mixed-genotype populations within DNA preparations. Very virulent UK isolate C12/130 induces extensive lymphoid atrophy, neurological manifestations and early mortality in young birds. We have recently reported the construction of several independent full-length bacterial artificial chromosome (BAC) clones of C12/130 capable of generating fully infectious viruses with significant differences in their pathogenicity profiles. Two of these clones (vC12/130-10 and vC12/130-15), which showed differences in virulence relative to each other and to the parental strain, had similar replication kinetics both in vitro and in vivo in spite of the fact that vC12/130-15 was attenuated. To investigate the possible reasons for this, the nucleotide sequences of both clones were determined. Sequence analysis of the two genomes identified mutations within eight genes. A single 494 bp insertion was identified within the genome of the virulent vC12/130-10 clone. Seven non-synonymous substitutions distinguished virulent vC12/ 130-10 from that of attenuated vC12/130-15. By sequencing regions of parental DNA that differed between the two BAC clones, we confirmed that C12/130 does contain these mutations in varying proportions. Since the individual reconstituted BAC clones were functionally attenuated in vivo and derived from a single DNA source of phenotypically very virulent C12/130, this suggests that the C12/130 virus population exists as a collection of mixed genotypes.
INTRODUCTION
Marek's disease (MD) is a highly contagious neoplastic and neuropathic disease of chickens (Calnek, 2001) . The causative agent is gallid herpesvirus type 2 (GaHV-2), a member of the genus Mardivirus within the subfamily Alphaherpesvirinae of the family Herpesviridae (Roizman et al. 1981; Lee et al. 2000) . Over the past 40 years the disease has been controlled with vaccines consisting of the related mardivirus herpesvirus of turkey, non-oncogenic serotype 2 strains (also known as gallid herpesvirus type 3), and attenuated derivatives of oncogenic GaHV-2 (Witter 2001a, b) . Unfortunately, over this same period field strains have evolved to greater virulence (Witter, 1997) . To understand the genetic changes involved in the generation of very virulent or very virulent plus (vv+) strains, the nucleotide sequences of large genomic regions and whole genomes representing the five pathotypes of GaHV-2 have been determined (Lee et al. 1971; Tulman et al. 2000; Niikura et al. 2006; Spatz & Silva, 2007a , 2007b . This information has shed some light on the mutations needed for attenuation, but it is complicated by the sheer number of mutations identified Volkening & Spatz, 2009 ). To avoid these limitations, scientists have cloned GaHV-2 genomes as bacterial artificial chromosomes (BAC) to get a 'molecular snapshot' of the mutations on a single molecule (Osterrieder & Vautherot, 2004) .
We have previously reported that the very virulent strain C12/130 isolated from Europe induces high mortality and atrophy of the lymphoid organs with increased tropism for the central nervous system (Barrow & Venugopal 1999; Barrow et al. 2003a, b) . To study the molecular basis for these biological characteristics, several BAC clones derived from a single source of C12/130 DNA were constructed and characterized in pathogenicity studies (Smith et al. 2011) . Surprisingly, viruses reconstituted from these clones and used to infect chickens had distinct pathogenic properties. One of the reconstituted viruses, named vC12/130-10, had mortality rates reaching that of the parental virus. Another reconstituted virus vC12/130-15 exhibited a relatively attenuated phenotype. To characterize further these clones, the in vitro replication kinetics in chicken embryo fibroblasts (CEFs), the relative copies numbers in peripheral blood lymphocytes (PBL) and feather follicle epithelial (FFE) cells in vivo were determined. As the BAC clones of these viruses represented single genome copies, the complete genomic nucleotide sequence of C12/130-10 and C12/130-15 was determined in the hope of identifying mutations involved in attenuation.
RESULTS
Characterization of reconstituted viruses from pC12/130-10 and pC12/130-15 DNA
Comparison of the in vitro replication rates of both vC12/ 130-10 and vC12/130-15 relative to wild-type virus ( Fig. 1) indicated that all viruses grew at nearly the same rate. The in vitro growth curves of the three viruses were analysed using a two-way ANOVA analysis and the F values for the viruses (3.038) were lower than the F crit (3.885), thereby indicating no significant differences between the growth of each virus in culture. We also analysed the in vivo replication kinetics of the three viruses by measuring the virus load in the DNA samples prepared from PBL and feather tips collected at different times after infection, using the meq-ovotransferrin duplex real-time qPCR test (Baigent et al. 2005) . GaHV-2 genome copy numbers in the PBL from birds infected with the three viruses were maintained at similar levels (~10 3 per 10 4 PBL) after the initial sampling period of 7 days post-infection (p.i.) (Fig.  2a) . Relative to the copy number in the PBL, DNA samples prepared from feather samples showed a significantly higher GaHV-2 genome copy number (10 6 per 10 4 FFE cells) from the second sampling period of 14 days p.i. The replication kinetics of the viruses, as measured by viral DNA content, were fairly comparable between the three viruses at late time points. However, at 4 days p.i., the parental strain replicated to approximately 1.5-2.0 logs higher than the reconstituted viruses (Fig. 2b) .
Deep sequencing of pC12/130-10 and pC12/130-15
The complete nucleotide sequences of BACs pC12/130-10 and pC12/130-15 were determined commercially by using 454 Life Sciences pyrosequencing. DNA sequences of pC12/ 130-10 and pC12/130-15 were assembled from 54 248 and 16 253 reads representing 30-fold and ninefold coverage at each base pair, respectively. Individual reads were initially assembled into large contigs representing the unique long Mutations that differ among C12/130-10 and C12/130-15
Lists of mutations that differ between C12/130-10 and C12/ 130-15 are presented in Tables 1-3 . The majority of intergenic differences occur in homopolymer stretches of mononucleotide reiterations between small novel genes within the R L region of the genome (Table 1) . Since pyrosequencing is limited in its ability to resolve mononucleotide reiterations greater than nine, these regions had to be resolved by using PCR and Sanger sequencing. Only five mutations mapped outside this region. Two occurred within the U L region: within the promoter of MDV057 encoding glycoprotein C and between MDV071.4 and MDV071.8. Two occurred within the a-like sequence involved in packaging the genome and one mapped to the 39 UTR of ICP4 and the promoter of RSORF1. Six mutations, resulting in a shift in reading frame (Table 2) , were mapped to eight genes (MDV078.2, MDV084.5/ MDV099.5, MDV085/MDV099, MDV085.3/MDV098.9, MDV086.5, MDV086.2/MDV097.6, MDV086.4 and MDV086.6). Most of these mutations mapped to mononucleotide reiterations within the R S /U S junction. Interestingly, this junction is quite polymorphic among strains (Spatz & Silva 2007a , 2007b ) and retrovirus sequences have been found within this region in some attenuated strains (Jones et al. 1993; Isfort et al. 1994) . Table 3 contains a list of the three synonymous and seven non-synonymous SNP mutations that were identified. Of the seven non-synonymous mutations, three changes (in bold, Table 3 ) are likely to affect the structure of the encoded proteins. These occur within the tegument protein MDV050 (ProASer), antisense RNA protein MDV083 (GlyAArg) and SORF3 kinase-like protein MDV090 (IleAMet) of the virulent C12/130-10 versus attenuated C12/130-15 strains, respectively.
The most noticeable difference between the genomes of C12/130-10 and C12/130-15 is the large 494 bp insertion between MDV071 (LORF10) and MDV072 (LORF11) in the genome of the virulent strain C12/130-10. This insertion occurs in a region containing repetitive sequences ( Fig. 3 ) and probably resulted from gene duplication. In comparison to other GaHV-2 viruses (virulent and attenuated) whose genomic sequence has been determined, this insertion is only found in virulent C12/130-10.
To determine whether the mutations that differ between C12/130-10 and C12/130-15 were present in the DNA preparation used to generate the two BAC constructs, and were not introduced during their construction, parental viral DNA was used as a template in amplification reactions to determine the nucleotide sequences of selected regions. All SNPs were confirmed to be present within the parental DNA in varying proportions. Interestingly, the primer pairs used to amplify the region containing the 494 bp insertion generated three bands that differed by approximately 500 bp (data not shown). Cloning and sequencing of these variants indicated that within the parental DNA three variants do exist. This is not likely to be a PCR artefact since the BAC clones C12/130-10 and C12/130-15 resulted from the cloning of two of the three (if not more) possible genomes present in the parental DNA preparation.
DISCUSSION
Comparison of the complete nucleotide sequences of two BAC constructs derived from DNA isolated from the very virulent C12/130 strain indicates generalized conservation at the nucleotide level. Few mutations were identified that could differentiate C12/130-10 from C12/130-15. Furthermore, phenotypically the in vitro and in vivo replication rates were very similar for the two reconstituted viruses. However, mortality rates did differ significantly among the two strains, and vC12-130-15 was less virulent than vC12/130-10. Both strains, however, were somewhat attenuated in comparison to the parental strain (Smith et al., 2011) . This could be due in part to the presence of the mini F cassette within the US2 genes of C12/130-10 and C12/130-15, as removal of the mini F and restoration of US2 within another GaHV-2 BAC (RB-1B) restored the reconstituted virus to the wild-type phenotype (Zhao et al. 2008 ). Therefore, the major question raised is which mutations between the BAC clones make C12/130-10 more virulent than C12/ 130-15. The data presented identified a number of mutations that can be grouped into three categories: mononucleotide reiterations, cistronic mutations and insertions.
The majority (72 %) of the differentiating mononucleotide reiterations ( Table 1) that occurred between ORFs mapped to the R L subgenomic region. This region contains the highest proportion of unique mardiviral-specific genes within the GaHV-2 genome. It is possible that these differences may affect the expression of neighbouring genes. Differences in mononucleotide reiterations were also identified in small novel ORFs within the internal R S /U S junctions. As reported with other GaHV-2 strains, these junctions contain significant sequence heterogeneity, not only with respect to differences in mononucleotide reiterations but also due to the presence of inserted retroviral sequences (Isfort et al. 1994; Spatz & Silva, 2007a , 2007b . Although some attenuated strains contain retroviral insertions within these junctions, a functional correlation between the inserted elements and an attenuated phenotype has not been reported. It is also unknown whether the short ORFs in the internal R S /U S junctions are expressed. These mutations will have to be examined using a functional approach.
In the absence of a functional examination of the reiteration mutations reported here, the sequencing data does identify two classes of mutations that could contribute to the differing phenotypes. The non-synonymous substitutions in the genes encoding the U L 37 tegument protein (MDV050), U L 39 ribonucleotide reductase (MDV052), ICP4
(MDV084), antisense RNA protein (MDV083), SORF3 (MDV090) and the insertion within the LORF10 promoter in the C12/130-10 genome are potential candidates for consideration. As shown in (MDV050) in C12/130-15 and the Gly substitution (MDV083) in C12/130-10 are probably most significant since they are predicted to affect the structure of the tegument protein and antisense RNA proteins, respectively. Whether these SNPs have a role in pathogenicity is not known, but there is evidence in the literature that SNPs are involved in virulence with other herpesviruses (Quinlivan et al. 2005 (Quinlivan et al. , 2007 Nugent et al. 2006; Goodman et al. 2007 ).
The insertion within the promoter region of LORF10 of virulent C12/130-10 is the only gross mutation identified in the comparison. None of the previously sequenced GaHV-2 genomes contain this insertion. In fact, three copies of the insertion were identified in the parental DNA by sequencing cloned PCR products. Since these insertions appear to be duplications, it is plausible that the duplicated repeat elements may affect the expression of MDV071 (LORF10). Seventy high scoring transcription factorbinding sites (e.g. CdXA homeobox, AP-1/jun, GATA-3, OCT-1, USF, HSF2, HSF1, NF-E1b and NF-E1C) have been found in this region by using the web-based TFsearch (Heinemeyer et al. 1998 (Heinemeyer et al. , 1999 . This may be of significance since LORF10 is a homologue of myristoylated proteins found in other alphaherpesviruses including MeHV-1, EHV-1, -4, -9, BHV-1, -5 and VZV. The role of this protein in the life cycle of herpesviruses is not well characterized, but there is some evidence that the BHV-1 homologue may influence the host's immune response by downregulating MHC-II expression in bovine monocytes (Schwyzer et al. 2002) . Recently, a polypeptide was demonstrated from an ORF (MDV072.2), which is antisense and overlapping to MDV072 encoding LORF11 (Tian et al. 2010) . It is plausible that the repeat element insertions in virulent C12/130-10 may affect the expression of this downstream 206 aa encoding gene.
In addition to mapping attenuating mutations, this paper provides additional evidence for the mixed-genotype nature of GaHV-2. Two BAC clones derived from a single viral DNA source of the very virulent strain C12/130 when reconstituted in vitro under minimal passages function differently in animal studies. Previously, we have used deep sequencing to identify mixed-genotype population in in vitro serial passage attenuation experiments (Spatz, 2010) . Although it is tempting to suggest that this large DNA virus exists as a quasispecies, additional animal experiments are needed to quantify the number of mutations per kilobase that can occur in animals infected with reconstituted virus from defined BAC recombinants.
METHODS
Virus and cells. Primary or secondary CEFs were maintained in Medium 199 (Gibco-BRL) supplemented with 10 % newborn calf serum. A viral stock of C12/130 wild-type was generated from splenoctyes extracted from chicken 6 days p.i. and passaged twice on CEFs. This was then used to generate the C12/130 BAC clones. The method for generating virus stocks in CEFs transfected with pC12/ 130-10 and pC12/130-15 is essentially that described by Petherbridge et al. (2004) .
In vitro growth kinetics. The rates of in vitro growth of the parental wild-type C12/130, vC12/130-10 and vC12/130-15 were studied by analysing the genome copy numbers at various time points p.i. For this, CEFs in 60 mm dishes were infected with 100 p.f.u. of virus stocks and incubated at 38.5 uC and 5 % CO 2 . At various time intervals (0, 12, 24, 48, 72, 96 and 120 h) p.i., DNA was extracted from the infected cells using the DNeasy 96 Blood & Tissue kit (Qiagen) and then used for determining the in vitro growth kinetics of the viruses by real-time qPCR by using methods described previously (Baigent et al. 2005) .
In vivo growth kinetics. Growth of the reconstituted viruses were examined in 2-week-old specific-pathogen- (Baigent et al. 2005) .
DNA sequencing and analysis. Large-scale preparation of BAC DNA from Escherichia coli DH10B cells harbouring pC12/130-10 and pC12/130-15 was achieved by silica-based affinity chromatography by using commercially available kits (Qiagen). Sequencing of 5.0 mg pC12/130-10 and pC12/130-15 was carried out commercially on a pyrosequencing platform, the Genome Sequencer 20 (GS20) System (454 Life Sciences), using an eight lane gasket. The construction of random libraries of pC12/130-10 and pC12/130-15 DNA was done by using the methodology described previously (Margulies et al. 2005) . DNA sequences of pC12/130-10 and pC12/130-15 were assembled from 54 248 and 16 253 reads, respectively, using GS De novo Assembler (454 Life Sciences) and Sequencher (Gene Codes). The average length of each read was 150 nt. The final sequences of pC12/ 130-10 and pC12/130-15 represent a 30-fold and ninefold coverage at each base pair, respectively. Ambiguities in the sequencing data of pC12/130-10 and pC12/130-15 were resolved by resequencing PCR products generated in reactions containing BAC DNA templates, high fidelity Platinum Taq DNA polymerase (Invitrogen) and custom primers using Sanger-based DNA sequencing methodology.
To investigate whether the mutations that differed among the two BAC clones were introduced during cloning manipulations, PCR products were generated in reactions that contained either pC12/130-10, pC12/130-15 or parental C2/130 DNA as templates with primers whose binding sites flanked the mutated regions. High fidelity Platinum Taq DNA polymerase (Invitrogen) was used in the amplification reactions and products were sequenced at the South Atlantic Area sequencing facility (Athens, GA) and Polymorphic DNA Technologies, Inc. (Alameda, CA) by using the BigDye terminator cycle Sanger sequencing protocol. These were analysed on a model ABI-3730 XL DNA Analyser (Applied Biosystems) by using dideoxy methodology. DNA sequences were maintained and analysed by using Lasergene (DNASTAR), NCBI Entrez and other web-based tools. Homology searches were conducted using the NCBI programs BLASTP and PSI-BLAST (Schäffer et al. 2001 ) with default settings. Published mRNA data (Maray et al. 1988; Peng et al. 1995; Peng & Shirazi 1996a, b) were compared to pC12/130-10 and pC12/130-15 genomes using PROT_Map (SoftBerry, Mount Kisco, NY). Transcription factor-binding sites were investigated by using the TFsearch program (Maray et al. 1988; Peng et al. 1995; Peng & Shirazi, 1996a, b; Heinemeyer et al. 1998 Heinemeyer et al. , 1999 . Multiple alignments of proteins and nucleotide sequences were generated using MAFFT, Multalign, MUSCLE and MEGA 4.1 (Corpet, 1988; Edgar, 2004; Kumar et al. 2004; Katoh et al. 2005) . Nucleotide sequence data of pC12/130-10 and pC12/130-15 have been assigned the GenBank accession numbers FJ436096 and FJ436097, respectively.
